Shari Annes | Investor Contact, Annes Associates |
Rachel King | Chief Executive Officer |
Helen Thackray | Senior Vice President, Clinical Development and Chief Medical Officer |
Brian Hahn | Chief Financial Officer |
Stephen Willey | Stifel, Nicolaus |
Irina Margine | Cowen and Company |
Peter Lawson | SunTrust Robinson Humphrey |
Jotin Marango | ROTH Capital Partners |
Good morning and thank you all for joining the GlycoMimetics call. At this time, all participants are in a listen-only mode.
Following management’s remarks, we will hold a brief question-and-answer session and at that time the lines will be open for you. [Operator Instructions]. I would now like to turn the call over to Shari Annes of the Investor Relations group at GlycoMimetics.